Key Takeaways IRWD posted Q2 earnings of $0.14 per share, beating expectations of a$0.02 loss.Q2 revenues were $85.2M, topping estimates but decreasing 9.7$85.7M despite higher overall product sales.Ironwood Pharmaceuticals (IRWD) reported adjusted earnings of 14 cents per share for the second quarter of 2025 against the Zacks Consensus Estimate of a loss of 2 cents. The company had reported breakeven earnings in the year-ago quarter.Total reve ...